RAPID MICRO BIOSYSTEMS, INC. (RPID): Nasdaq/NYSE listing notice — Rapid Micro Biosystems receives Nasdaq delisting notice over bid price below $1.00

RAPID MICRO BIOSYSTEMS, INC.

Received Nasdaq deficiency notice on Sept 13, 2023; bid price below $1.00 for 30 consecutive business days ending Sept 11, 2023.
180-day compliance period expires March 11, 2024; must close at $1.00+ for 10 consecutive days.
Since Sept 12, bid price has been above $1.00 for six consecutive business days through Sept 19.
If not compliant by March 2024, may transfer to Nasdaq Capital Market for another 180-day cure period.
No immediate delisting; company monitors and will take reasonable measures.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

RAPID MICRO BIOSYSTEMS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

) had closed below $1.00 per share for the thirty (30) consecutive business days (July 31, 2023 through September 11, 2023) and that the Company therefore is not in compliance with the minimum bid price requirement for continued inclusion on the Nasdaq Global Select Market under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). The notification has no immediate effect on the listing of the Company’s common stock on Nasdaq. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has a period of 180 calendar days to regain compliance with the Bid Price Requirement, which wi

View on SEC.gov

18 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

RAPID MICRO BIOSYSTEMS, INC. filing history →

Source: SEC EDGAR

accession 0001380106-23-000161

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.